American International Group, Inc. Sigilon Therapeutics, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.74 - $1.64 $5,585 - $12,378	-7,548 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.24 - $3.03 $658 - $1,608	-531 Reduced 6.57%	7,548 $11,000
Q4 2021 Feb 11, 2022	SELL	$2.58 - $6.13 $624 - $1,483	-242 Reduced 2.91%	8,079 $22,000
Q3 2021 Nov 12, 2021	BUY	$4.42 - $10.61 $18,506 - $44,424	4,187 Added 101.28%	8,321 $47,000
Q2 2021 Aug 13, 2021	SELL	$9.15 - $20.17 $3,348 - $7,382	-366 Reduced 8.13%	4,134 $44,000
Q1 2021 May 07, 2021	BUY	$18.76 - $40.91 $84,420 - $184,094	4,500 New	4,500 $101,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.